Part II: How FDA predetermined change control plans create a market for AI medical device validation, clinical data procurement, software release controls, and recurring regulatory evidence services

FDA’s August 2025 guidance lets AI device makers pre-authorize future model updates. That is not a blank check. Every update still needs a full evidence package before it ships.

Beacon Biosignals got 510k clearance in March 2024 with one of these authorized plans covering sleep-staging algorithm updates AND related processing. The surrounding pipeline ma…